Amgen Inc. (NASDAQ:AMGN) is one of the stocks on Jim Cramer’s recent game plan. Cramer said that he heard good things about the company during the JPMorgan Healthcare Conference, as he commented: With ...
Investor's Business Daily on MSN
Dow Jones leader Amgen leads these biotech stocks heading into Q4 earnings season
Dow Jones biotech giant Amgen, along with fellow biotech stocks Gilead and Vertex, are due to report fourth-quarter earnings ...
Zacks Investment Research on MSN
Silver economy boom: Investing in healthcare's aging tailwinds
An updated edition of the December 16, 2025, article. An aging U.S. population is becoming a first-order driver of consumption reallocation. Going by the data from the United States Census Bureau, by ...
The plant will help make Lilly's experimental drug called retatrutide, which has shown the highest weight loss seen to date in a late-stage trial.
Prompt injections have become one of the biggest emerging threats to the modern home as AI adoption grows. It's a new era of malware -- and one that requires new defenses. Tyler Lacoma Editor / Home ...
New Afrezza prescribing information outlines higher starting dose conversions for patients transitioning from mealtime insulin to improve glycemic control.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results